Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|14|2|72-82

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.14, Iss.2, 2014-09, pp. : 72-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FKBP Ligands as Novel Therapeutics for Neurological Disorders

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 4, 2001-11 ,pp. : 377-397

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals in Neurological and Psychiatric Disorders

By  

Current Clinical Pharmacology, Vol. 3, Iss. 2, 2008-05 ,pp. : 99-107

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders

By Bernardo Carmina G   Singh Vivek   Thompson Peter M  

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 435-445

Informa Healthcare

Access to resources Recommend Favorite

Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1595-1611

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase Inhibitors as Therapeutics for Traumatic Brain Injury

By  

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 332-342

Bentham Science Publishers

Access to resources Recommend Favorite